Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-27T13:58:20.799Z Has data issue: false hasContentIssue false
  • English
  • Français

Narcolepsy Secondary to Fourth Ventricular Subependymoma

Published online by Cambridge University Press:  18 September 2015

T.K.F. Ma ,
L.C. Ang ,
M. Mamelak ,
S.J. Kish ,
B. Young  and
A.J. Lewis
T.K.F. Ma
Affiliation:
Division of Pathology, Sunnybrook Health Science Centre, University of Toronto, Toronto
L.C. Ang*
Affiliation:
Division of Pathology, Sunnybrook Health Science Centre, University of Toronto, Toronto
M. Mamelak
Affiliation:
Department of Psychiatry, Boycrest Centre, University of Toronto, Toronto
S.J. Kish
Affiliation:
Clarke Institute of Psychiatry, University of Toronto, Toronto
B. Young
Affiliation:
Division of Pathology, Sunnybrook Health Science Centre, University of Toronto, Toronto
A.J. Lewis
Affiliation:
Division of Pathology, Sunnybrook Health Science Centre, University of Toronto, Toronto
*
Division of Pathology (Neuropathology) E419. Sunnybrook Health Science Centre, University of Toronto. 2075 Bayview Avenue, North York. Ontario. Canada M4N 3M5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Secondary (symptomatic) narcolepsy is rare. We report a subependymoma of the fourth ventricle associated with narcolepsy. The patient was a 50-year-old woman with a long history of narcolepsy who died of colonic carcinoma with no cerebral metastasis. She was positive for HLA-DR2. At autopsy there was a tumour dorsal to the fourth ventricle which involved the midbrain tectum and rostral pons. Histologic examination of the tumour confirmed it to be a subependymoma.

Methods:

Review of the previous cases of secondary narcolepsy was made with particular reference to the anatomical location of the lesions.

Results:

Most of the lesions were found around the third ventricle and rostral brainstem.

Conclusions:

Knowing the anatomical localization of the pathological changes in secondary narcolepsy could be important in improving our understanding of its pathogenesis.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 23 , Issue 1 , February 1996 , pp. 59 - 62
Copyright
Copyright © Canadian Neurological Sciences Federation 1996

References

1.Anderson, M, Salmon, MV.Symptomatic cataplexy. J Neurol Neurosurg Psychiatry 1977; 40: 186–191.CrossRefGoogle ScholarPubMed
2.Stahl, SM, Layzer, RB, Aminoff, MJ, Townsend, JJ, Feldon, S.Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology 1980; 30: 1115–1118.CrossRefGoogle Scholar
3.Pritchard, PB, Dreifuss, FE, Skinner, RL, Pickett, JB, Biggs, PJ.Symptomatic narcolepsy (Abstract). Neurology 1983; 33 (Suppl 2): 239.Google Scholar
4.Rubinstein, I, Grey, TA, Moldofsky, H, Hoffstein, V.Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation. Chest 1988; 94: 205–206.CrossRefGoogle ScholarPubMed
5.Aldrich, MS, Naylor, MW.Narcolepsy associated with lesions of the diencephalon. Neurology 1989; 39: 1505–1508.CrossRefGoogle ScholarPubMed
6.Rivera, VM, Meyer, JS, Hata, T, Ishikawa, Y, lami, A.Narcolepsy following cerebral hypoxic ischemia. Ann Neurol 1986; 19: SOS-SOS.CrossRefGoogle ScholarPubMed
7.Matsuda, Y, Neshige, R, Endo, C, Abe, M, Kuroda, Y.A case of upper brainstem infarction developing symptomatic narcolepsy after the administration of anti-convulsant drugs. (Japanese with English abstract) Clinical Neurology 1991; 31: 750–753.Google ScholarPubMed
8.Gurewitz, R, Blum, I, Lavie, P, et al. Recurrent hypothermia, hypersomnolence, central sleep apnea, hypodipsia, hypernatremia, hypothyroidism, hyperprolactinemia and growth hormone deficiency in a boy-treatment with clomipramine. Acta Endocrinol (Copenh) 1986 (Suppl); 279: 468–472.Google Scholar
9.Schwartz, WJ, Stakes, JW, Hobson, JA.Transient cataplexy after removal of a craniopharyngioma. Neurology 1984; 34: 1372–1375.CrossRefGoogle ScholarPubMed
10.Kowatch, RA, Parmelee, DX, Morin, CM.Narcolepsy in a child following removal of a craniopharyngioma. Sleep Res 1989; 18: 250.Google Scholar
11.Onofrj, M, Curatola, L, Ferracci, F, Fulgente, T.Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject. J Neurol Neurosurg Psychiatry 1992; 55: 852–853.CrossRefGoogle Scholar
12.Kish, SJ, Mamelak, M, Slimovitch, C, et al. Brain neurotransmitter changes in human narcolepsy. Neurology 1992; 42: 229–234.CrossRefGoogle ScholarPubMed
13.Matsumura, A, Ahyai, A, Hori, A, et al. Intracerebral subependymoma clinical and neuropathological analysis with special reference to the possible existence of a less benign variant. Acta Neurochir 1989; 96: 15–25.CrossRefGoogle Scholar
14.Scheithauer, BW.Symptomatic subependymoma. Report of 21 cases with review of the literature. J Neurosurg 1978; 49: 689–696.CrossRefGoogle ScholarPubMed
15.Aldrich, MS.The neurobiology of narcolepsy-cataplexy. Prog Neurobiol 1993; 41: 533–541.CrossRefGoogle ScholarPubMed
16.Honda, Y, Juji, T, Matsuki, K, et al. HLA-DR2 and DW2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep 1986,9: 133–142.CrossRefGoogle ScholarPubMed
17.Fernandez, JM, Sadaba, F, Villaverde, FJ, Alvaro, LC, Cortina, C.Cataplexy associated with midbrain lesion. Neurology 1995; 45: 393.CrossRefGoogle ScholarPubMed
18.D’Cruz, OF, Vaughn, BV, Gold, SH, Greenwood, RS.Symptomatic cataplexy in pontomedullary lesions. Neurology 1994; 44: 2189.Google ScholarPubMed